Forum

Changes In Cardiova...
 
Notifications
Clear all

Changes In Cardiovascular Biomarkers Associated With The Sodium Glucose Cotransporter-2 (sglt2) Inhibitor Ertugliflozin In Patients With Chronic Kidney Disease And Type 2 Diabetes

No topics were found here

Share: